Royalty says it will pay $12.50 in cash for each share of Elan.
Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders GENEVA , May 21, 2013 /PRNewswire...
Peregrine rises on agreement for late-stage study WASHINGTON (AP) — Shares of Peregrine Pharmaceuticals Inc. surged Monday after the company said it...
An interim analysis showed the drug wasn't helping patients live longer
Rise and shine, everyone. Another busy day is on the way, and we are no exception. We have an interesting meeting planned and, of course, various...
The short work week is drawing to a close. By now, though, you most likely have settled back into your routine. We know we have. As you ready for the next meeting and report, grab a cup of something hot and catch up with these...
Takeda Seeks FDA Approval For Actos Follow-Up (Bloomberg News)
Sanofi Pooh-Poohs Lawsuit Charging Acomplia Data Was Hidden (Reuters)
Drugmakers Vie For Magic Weight-Loss Pill (MSNBC/AP)
